David T. Scadden, Jr., MD
Director, Center for Regenerative Medicine
Co-Director, Harvard Stem Cell Insitutite
Director, Hematologic Malignancies & Experimental Hematology
- Department of Medicine
- Cancer Center
- Multiple Myeloma
- Clinical Interests
- Stem cells
- Regenerative medicine
- Hematologic malignancies
- Boston: Massachusetts General Hospital
- Medical Education
- MD, Case Western Reserve University School of Medicine
- Residency, Brigham and Women's Hospital
- Fellowship, Brigham and Women's Hospital
- Fellowship, Dana Farber Cancer Institute
- Board Certifications
- Internal Medicine, American Board of Internal Medicine
- Medical Oncology, American Board of Internal Medicine
- Hematology, American Board of Internal Medicine
- Accepting New Patients
- Insurances Accepted
- Aetna Health Inc.
Blue Cross Blue Shield - Blue Care 65
Blue Cross Blue Shield - Indemnity
Blue Cross Blue Shield - Managed Care
Blue Cross Blue Shield - Partners Plus
Cigna (PAL #'s)
Fallon Community HealthCare
ForMost Managed Care
Great-West Healthcare (formally One Health Plan)
Harvard Pilgrim Health Plan - ACD
Harvard Pilgrim Health Plan - PBO
Health Care Value Management (HCVM)
Humana/Choice Care PPO
Neighborhood Health Plan - ACD
Neighborhood Health Plan - PBO
OSW - Maine
OSW - New Hampshire
OSW - Rhode Island
Private Health Care Systems (PHCS)
Tufts Health Plan
Tufts Medicare Advantage PPO
United Healthcare (non-HMO) - ACD
United Healthcare (non-HMO) - PBO
ResearchMy interest is in understanding how stem cell biology can be used to develop more effective therapies for blood diseases and cancer.
Dr. David Scadden shares his thoughts on the new executive order.
MGH Hotline 05.14.10 Researchers from the Center for Regenerative Medicine gathered with Cheryl Chagnon, Heather Reid and their families April 6 to celebrate the donation of an important piece of research equipment -- the Nexelcom Cellometer Vision automatic cell analyzer.
MGH Hotline 08.06.10 In General awards and honors
MGH Hotline 12.24.10 In General awards and honors
MGH Hotline 5.27.11
In General awards and honors
A new study by Harvard researchers at Massachusetts General Hospital indicates that “good” cells can become cancerous because of exposure to a “bad” environment within the body — similarly to the way a “good boy” may turn to crime when exposed to the pressures of life in a crime-ridden neighborhood.
MGH investigators have identified a new mechanism that controls the number of the stem cells that give rise to all blood and immune system cells, an advance that may improve treatment of blood system cancers.
Center for Regenerative Medicine
Harvard Stem Cell Institute
185 Cambridge Street
Boston, MA 02114
Call the Massachusetts General Hospital physician referral service at 800-711-4644.
Mass General accepts most health insurance plans. Find out what you need to know before coming to Mass General.
Driving to Mass General? Get driving directions or locate a parking lot on the hospital's main campus.